[18F]FDG

DRUG4 trials

Sponsors

Washington University School of Medicine, Turku University Hospital, Stanford University, National Cancer Institute (NCI)

Conditions

Bladder CancerCholangiocarcinomaChronic PainGastric CancerHepatocellular CarcinomaLung DiseaseMesotheliomaObesity

Phase 1

Use of PET/MR Imaging in Chronic Pain

CompletedNCT03195270

Stanford UniversityChronic Pain

Start: 2014-11-24End: 2022-01-20Updated: 2023-05-16

Phase 2

18F-Fibroblast Activation Protein Inhibitor ([18F]FAPI-74) PET Imaging for Cancer Detection

RecruitingNCT06503146

National Cancer Institute (NCI)Bladder Cancer, Cholangiocarcinoma, Gastric Cancer +7

Start: 2025-09-09End: 2030-06-01Target: 320Updated: 2026-05-19

Unknown Phase

PET Assessment of Acute Lung Transplant Rejection

TerminatedNCT02204202

Washington University School of MedicineLung Disease

Start: 2014-02-28End: 2017-02-04Updated: 2020-10-08

CB1 Receptors in Human Brown Adipose Tissue

CompletedNCT02941172

Turku University HospitalObesity

Start: 2015-01-31End: 2017-12-30Updated: 2018-12-20

Related Papers

Sigma-1 Receptor Changes Observed in Chronic Pelvic Pain Patients: A Pilot PET/MRI Study

Frontiers in Pain Research2021-10-2010 citations